Literature DB >> 758867

Moist bacterial strike-through of surgical materials: confirmatory tests.

H Laufman, J D Siegal, S C Edberg.   

Abstract

New tests consisting of modifications of the inverted Mason jar test confirm our previously reported studies which showed that woven and nonwoven surgical materials vary greatly in their ability to serve as barriers against moist bacterial strike-through. Among the woven materials, only tightly woven Pima cloth or materials treated with Quarpel waterproofing process or with polythene layer lamination was invariably resistant. However, tight-woven Pima cloth, which had been treated with Quarpel became permeable after 100 washing-sterilizing cycles. Of the nonwoven materials, single-layer nonwoven materials tended to unevenly permeable to moist bacterial strike-through. Only the front and sleeves of nonwoven gowns reinforced with polyethelene layer were invariably resistant to moist contamination.

Entities:  

Mesh:

Year:  1979        PMID: 758867      PMCID: PMC1396949          DOI: 10.1097/00000658-197901000-00014

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  2 in total

1.  Strike-through of moist contamination by woven and nonwoven surgical materials.

Authors:  H Laufman; W W Eudy; A M Vandernoot; C A Harris; D Liu
Journal:  Ann Surg       Date:  1975-06       Impact factor: 12.969

2.  Intraoperative bacterial transmission.

Authors:  J A Moylan; E Balish; J Chan
Journal:  Surg Gynecol Obstet       Date:  1975-11
  2 in total
  2 in total

1.  The evaluation of fabrics in relation to their use as protective garments in nursing and surgery. III. Wet penetration and contact transfer of particles through clothing.

Authors:  C A Mackintosh; O M Lidwell
Journal:  J Hyg (Lond)       Date:  1980-12

2.  Tourniquets and exsanguinators: a potential source of infection in the orthopedic operating theater?

Authors:  Stephen A Brennan; Raymond J Walls; Elizabeth Smyth; Talal Al Mulla; John M O'Byrne
Journal:  Acta Orthop       Date:  2009-04       Impact factor: 3.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.